These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7859838)
1. HCV, HIV, HBV and HDV infections in intravenous drug addicts. Coppola RC; Manconi PE; Piro R; Di Martino ML; Masia G Eur J Epidemiol; 1994 Jun; 10(3):279-83. PubMed ID: 7859838 [TBL] [Abstract][Full Text] [Related]
2. Sexual behaviour and multiple infections in drug abusers. Coppola RC; Masia G; di Martino ML; Carboni G; Muggianu E; Piro R; Manconi PE Eur J Epidemiol; 1996 Oct; 12(5):429-35. PubMed ID: 8905301 [TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus]. de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of blood-borne viral infections in Afghanistan. Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354 [TBL] [Abstract][Full Text] [Related]
6. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme. Krogsgaard K; Wantzin P; Mathiesen L; Ring-Larsen H Scand J Gastroenterol; 1991 Mar; 26(3):275-80. PubMed ID: 1906632 [TBL] [Abstract][Full Text] [Related]
7. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts. Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317 [TBL] [Abstract][Full Text] [Related]
9. A multicenter study of viral hepatitis in a United States hemophilic population. Troisi CL; Hollinger FB; Hoots WK; Contant C; Gill J; Ragni M; Parmley R; Sexauer C; Gomperts E; Buchanan G Blood; 1993 Jan; 81(2):412-8. PubMed ID: 7678517 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
11. Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy. Torimiro JN; Nanfack A; Takang W; Keou CK; Joyce AN; Njefi K; Agyingi K; Domkam I; Takou D; Moudourou S; Sosso S; Mbu RE BMC Pregnancy Childbirth; 2018 Dec; 18(1):504. PubMed ID: 30577760 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. Francisci D; Baldelli F; Papili R; Stagni G; Pauluzzi S Eur J Epidemiol; 1995 Apr; 11(2):123-6. PubMed ID: 7672063 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece. Roumeliotou-Karayannis A; Tassopoulos N; Karpodini E; Trichopoulou E; Kotsianopoulou M; Papaevangelou G Eur J Epidemiol; 1987 Jun; 3(2):143-6. PubMed ID: 3475213 [TBL] [Abstract][Full Text] [Related]
14. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users. Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Oliveira ML; Bastos FI; Telles PR; Yoshida CF; Schatzmayr HG; Paetzold U; Pauli G; Schreier E Braz J Med Biol Res; 1999 Sep; 32(9):1107-14. PubMed ID: 10464387 [TBL] [Abstract][Full Text] [Related]
17. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV. Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of HBV, HDV, HCV, and HIV infection during pregnancy in northern Benin. De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Ndayaké J; Zaongo D; Priuli G; Viganò P; Clerici P J Med Virol; 2014 Aug; 86(8):1281-7. PubMed ID: 24777580 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. Nicolini LA; Taramasso L; Schiavetti I; Giannini EG; Beltrame A; Feasi M; Cassola G; Grasso A; Bartolacci V; Sticchi L; Picciotto A; Viscoli C; Antivir Ther; 2015; 20(2):193-7. PubMed ID: 24963642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]